Issue 14, 2021

Rational design of a lysosome-targeting and near-infrared absorbing Ru(ii)–BODIPY conjugate for photodynamic therapy

Abstract

A Ru(II)–BODIPY conjugate has been rationally designed and exhibits an intense absorption in the NIR region to boost lysosome-targeted PDT in vitro and in vivo. The advantages of Ru(II) and BODIPY were successfully instilled into the conjugate to yield highly effective PDT efficacy against malignant melanoma A375 cells (PI = 3448) and A375 mice xenografts.

Graphical abstract: Rational design of a lysosome-targeting and near-infrared absorbing Ru(ii)–BODIPY conjugate for photodynamic therapy

Supplementary files

Article information

Article type
Communication
Submitted
18 Oct 2020
Accepted
11 Jan 2021
First published
11 Jan 2021

Chem. Commun., 2021,57, 1790-1793

Rational design of a lysosome-targeting and near-infrared absorbing Ru(II)–BODIPY conjugate for photodynamic therapy

L. Qiao, J. Liu, Y. Han, F. Wei, X. Liao, C. Zhang, L. Xie, L. Ji and H. Chao, Chem. Commun., 2021, 57, 1790 DOI: 10.1039/D0CC06926D

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements